Cologuard improves sensitivity in colorectal cancer screening over a leading FIT.*
Sensitivity for all stages of cancer
Sensitivity for stages I-III of cancer
Sensitivity for high-grade dysplasia
Cologuard results are based on 11 biomarkers–10 sDNA, plus hemoglobin, while FIT tests are based on hemoglobin alone
*OC FIT-CHEK, Polymedco, Inc.
†These specificity measures excluded CRC and AA for both tests.
REFERENCE 1. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297.